Effect of Proinflammatory Cytokines on the Interplay between Roxithromycin, HMR 3647, or HMR 3004 and Human Polymorphonuclear Neutrophils

Por Vazifeh, D., Bryskier, A., Labro, M. T.
Publicado em 2000

Antibiotic Susceptibilities of Parachlamydia acanthamoeba in Amoebae

Por Maurin, M., Bryskier, A., Raoult, D.
Publicado em 2002

Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages.

Por Rastogi, N, Labrousse, V, Bryskier, A
Publicado em 1995

In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined wit...

Por Klugman, K P, Capper, T, Bryskier, A
Publicado em 1996

In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICs.

Por Rastogi, N, Goh, K S, Bryskier, A
Publicado em 1993

Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.

Por Rastogi, N, Goh, K S, Bryskier, A
Publicado em 1994

Interactions between HMR 3647, a New Ketolide, and Human Polymorphonuclear Neutrophils

Por Vazifeh, D., Preira, A., Bryskier, A., Labro, M. T.
Publicado em 1998

In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.

Por Rastogi, N, Goh, K S, Bryskier, A, Devallois, A
Publicado em 1996

Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithro...

Por Rastogi, N, Goh, K S, Bryskier, A, Devallois, A
Publicado em 1996

Comparative Activities of Telithromycin (HMR 3647), Levofloxacin, and Other Antimicrobial Agents against Human Mycoplasmas

Por Bebear, C. M., Renaudin, H., Bryskier, A., Bebear, C.
Publicado em 2000

Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.

Por Brisson, A M, Bryskier, A, Millerioux, L, Fourtillan, J B
Publicado em 1984

In Vivo Pharmacodynamics of HMR 3270, a Glucan Synthase Inhibitor, in a Murine Candidiasis Model

Por Andes, D., Marchillo, K., Lowther, J., Bryskier, A., Stamstad, T., Conklin, R.
Publicado em 2003

In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.

Por Frean, J A, Arntzen, L, Capper, T, Bryskier, A, Klugman, K P
Publicado em 1996

The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.

Por Araujo, F G, Khan, A A, Slifer, T L, Bryskier, A, Remington, J S
Publicado em 1997

Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.

Por Lenfant, B, Namour, F, Logeais, C, Coussediere, D, Rivault, O, Bryskier, A, Surjus, A
Publicado em 1995

Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactam.

Por Chantot, J F, Klich, M, Teutsch, G, Bryskier, A, Collette, P, Markus, A, Seibert, G
Publicado em 1992